Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrazino[2,1-c][1,2,4]triazines as Wnt/CBP/catenin signaling pathway inhibitors

Substituted pyrazino[2,1-c][1,2,4]triazines as Wnt/CBP/catenin signaling pathway inhibitors

US Patent 12486275 · Granted Dec 2, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PCNA inhibitors2025
CBP/Catenin antagonists for enhancing asymmetric division of somatic stem cells2018
Substituted pyrazino[1,2-a]pyrimidines useful as CBP/catenin antagonists for enh2016
Reverse-turn mimetics and method relating thereto2014
Alpha-helix mimetics and methods relating to the treatment of fibrosis2013
Reverse-turn mimetics and method relating thereto2012
Substituted imidazo[1,2-A]pyrazine derivatives as alpha-helix mimetics and metho2012
Reverse-turn mimetics and method relating thereto2012
Reverse-turn mimetics and method relating thereto2012
Reverse-turn mimetics and method relating thereto2012
Reverse-turn mimetics and method relating thereto2011
Alpha-helix mimetics and methods relating to the treatment of fibrosis2011